Dr. Ann Mohrbacher received her medical degree from Harvard Medical School and completed an internship and residency in internal medicine at Brigham & Women’s Hospital. In addition, she was a fellow in clinical oncology/tumor biology at the Dana-Farber Cancer Institute. Dr. Mohrbacher is currently an associate professor of clinical medicine at Keck School of Medicine, University of Southern California in Los Angeles.

Dr. Mohrbacher, a devoted educator, researcher and medical practitioner, is a member of the Southern California Lymphoma Group and currently belongs to a number of university related committees, such as the Post-Graduate Education Committee and the Clinical Investigations Committee. She has been published in a number of medical journals and has been invited to lecture on topics including radioimmunotherapy of non-Hodgkin’s lymphoma and B-cell targeted therapy of rheumatoid arthritis. Dr. Mohrbacher’s hematology related research interests and activities include bone marrow transplantation.

Faculty Disclosure
Dr. Ann Mohrbacher has received honoraria related to speakers’ bureau activities from Celgene Corporation, Genentech, Inc. and Millennium Pharmaceuticals, Inc., as well as consultant fees from PDL BioPharma, Inc.